Conceptus, Inc. ( CPTS) Announces Dates of 18th Annual Congress of the European Society for Gynecologic Endoscopy
By Ben Zinga
October 29, 2009 6:20 AM
October 29, 2009 6:20 AM
Conceptus, Inc. (Nasdaq: CPTS), the company that developed the Essure ® procedure, the very first non-incisional permanent birth control method proven efficacy, announced that at 18th Annual Congress of the European Society for Gynecologic Endoscopy (European Society for Gynecological Endoscopy, ESGE), to be held in Florence, Italy, October 28 to 31 next, will be emphasized to the clinical success of the procedure Essure ®.
The accepted 12 ESGE compendiums devoted to Essure ® procedure, which will be presented by speakers from across Europe who recognize this procedure as the reference standard for sterilization hysteroscopy.
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
We're Loving
